Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 2 (3 Cyano 4 isobutoxy phenyl) 4 methyl thiazole 5 carboxylic Acid. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN103012311A details a novel etherification method using distilled isobutane bromide to eliminate n-propoxy impurities, ensuring superior API quality and supply reliability.
Patent CN110878064A reveals a breakthrough synthesis route for febuxostat impurities, boosting total yield from 0.2% to 43% via strategic intermediate sequencing.
Novel non-toxic route for 2-(3-cyano-4-isobutoxy phenyl)-4-methyl-thiazole-5-carboxylic acid avoiding cyanides and corrosive acids.